Article Details
Retrieved on: 2022-07-02 15:32:56
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Karpas Strategies LLC's holdings in Pfizer were worth $7,182,000 as of its most recent SEC filing. Other institutional investors have also recently ...
Article found on: www.defenseworld.net
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here